Abstract
Abstract
Background
Prolonged air leak (PAL) is the most frequent complication after pulmonary resection. Several measures have been described to prevent the occurrence of PAL in high-risk patients, however, the potential role of mesenchymal stem cells (MSCs) applied in the parenchymal suture line to prevent postoperative air leak in this setting has not been fully addressed.
Objective
To analyse the feasibility, safety and potential clinical efficacy of the implantation of autologous MSCs embedded in Tissucol Duo® as a prophylactic alternative to prevent postoperative prolonged air leak after pulmonary resection in high-risk patients.
Study design
Phase I/II single-arm prospective clinical trial.
Methods
Six patients with high risk of PAL undergoing elective pulmonary resection were included. Autologous bone marrow-derived MSCs were expanded at our Good Manufacturing Practice (GMP) Facility and implanted (embedded in a Tissucol Duo® carrier) in the parenchymal suture line during pulmonary resection surgery. Patients were monitored in the early postoperative period and evaluated for possible complications or adverse reactions. In addition, all patients were followed-up to 5 years for clinical outcomes.
Results
The median age of patients included was 66 years (range: 55–70 years), and male/female ratio was 5/1. Autologous MSCs were expanded in five cases, in one case MSCs expansion was insufficient. There were no adverse effects related to cell implantation. Regarding efficacy, median air leak duration was 0 days (range: 0–2 days). The incidence of PAL was nil. Radiologically, only one patient presented pneumothorax in the chest X-ray at discharge. No adverse effects related to the procedure were recorded during the follow-up.
Conclusions
The use of autologous MSCs for prevention of PAL in patients with high risk of PAL is feasible, safe and potentially effective.
Trial registration No. EudraCT: 2013-000535-27. Clinicaltrials.gov idenfier: NCT02045745.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)
Reference47 articles.
1. Pischik VG, Maslak OS, Obornev AD, Zinchenko EI, Kovalenko AI. Risk factors and outcomes of prolonged air leak after pulmonary resections. Indian J Thorac Cardiovasc Surg. 2019;35(4):564–8.
2. Stolz AJ, Schützner J, Lischke R, Simonek J, Pafko P. Predictors of prolonged air leak following pulmonary lobectomy. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2005;27(2):334–6.
3. ests_2022_silver_book.pdf [Internet]. [cited 2022 Oct 22]. https://www.ests.org/_userfiles/pages/files/database_reports/ests_2022_silver_book.pdf
4. Gómez de Antonio D, Crowley Carrasco S, Romero Román A, Royuela A, Sánchez Calle Á, Obiols Fornell C, et al. Surgical risk following anatomic lung resection in thoracic surgery: a prediction model derived from a spanish multicenter database. Arch Bronconeumol. 2021;S0300-2896(21)00070-3.
5. Varela G, Jiménez MF, Novoa N, Aranda JL. Estimating hospital costs attributable to prolonged air leak in pulmonary lobectomy. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2005;27(2):329–33.